Drug profile · INN
brinzolamide + brimonidine
SIMBRINZA 1%/0.2%
brinzolamide + brimonidine (SIMBRINZA 1%/0.2%) is an FDA-listed pharmaceutical active ingredient. Associated with Novartis Pharmaceuticals.
TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — brinzolamide + brimonidine
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.81
Quick answer
brinzolamide + brimonidine (SIMBRINZA 1%/0.2%) is an FDA-listed pharmaceutical active ingredient. Associated with Novartis Pharmaceuticals.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Frequently asked questions
What is brinzolamide + brimonidine?
brinzolamide + brimonidine (SIMBRINZA 1%/0.2%) is an FDA-listed pharmaceutical active ingredient. Associated with Novartis Pharmaceuticals.
What is the brand name for brinzolamide + brimonidine?
SIMBRINZA 1%/0.2% is a marketed brand name for brinzolamide + brimonidine. Check FDA Drugs@FDA for the current US label holder and prescribing information.